Patents by Inventor Emmanuel-S Cohen-Laroque

Emmanuel-S Cohen-Laroque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6631291
    Abstract: A closed loop method and apparatus for controlling the administration of an hypnotic drug to a patient. Electroencephalographic (EEG) signal data is obtained from the patient. At least one measure of the complexity of the EEG signal data is derived from the data. The complexity measure may comprise the entropy of the EEG signal data. The EEG signal data complexity measure is used as the feedback signal in a control loop for an anesthetic delivery unit to control hypnotic drug administration to the patient in a manner that provides the desired hypnotic level in the patient. An EEG signal complexity measure obtained from the cerebral activity of the patient can be advantageously used in conjunction with a measure of patient electromyographic (EMG) activity to improve the response time of hypnotic level determination and of the feedback control of drug administration. A pharmacological transfer function may be used, along with pharmacokinetic and pharmacodynamic models.
    Type: Grant
    Filed: May 21, 2001
    Date of Patent: October 7, 2003
    Assignee: Instrumentarium Corp.
    Inventors: Hanna Viertïo-Oja, Emmanuel-S Cohen-Laroque
  • Publication number: 20020173729
    Abstract: A closed loop method and apparatus for controlling the administration of an hypnotic drug to a patient. Electroencephalographic (EEG) signal data is obtained from the patient. At least one measure of the complexity of the EEG signal data is derived from the data. The complexity measure may comprise the entropy of the EEG signal data. The EEG signal data complexity measure is used as the feedback signal in a control loop for an anesthetic delivery unit to control hypnotic drug administration to the patient in a manner that provides the desired hypnotic level in the patient. An EEG signal complexity measure obtained from the cerebral activity of the patient can be advantageously used in conjunction with a measure of patient electromyographic (EMG) activity to improve the response time of hypnotic level determination and of the feedback control of drug administration. A pharmacological transfer function may be used, along with pharmacokinetic and pharmacodynamic models.
    Type: Application
    Filed: May 21, 2001
    Publication date: November 21, 2002
    Inventors: Hanna Viertio-Oja, Emmanuel-S Cohen-Laroque
  • Patent number: 6120443
    Abstract: A method comprising a step (10) of acquiring a patient heart activity signal, a signal shaping step (11) comprising a step (19) of converting the analog signal into a digital signal, a step (12) of sensing a periodic wave in the signal, a step (13) of calculating time intervals between the periodic waves, a step (14) of determining digital time interval series, a step (15) of calculating a fractal dimension of the digital series, and a step (16) of calculating the depth of anesthesia on the basis of the fractal dimension.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: September 19, 2000
    Inventor: Emmanuel-S. Cohen-Laroque
  • Patent number: RE41291
    Abstract: A closed loop method and apparatus for controlling the administration of an hypnotic drug to a patient. Electroencephalographic (EEG) signal data is obtained from the patient. At least one measure of the complexity of the EEG signal data is derived from the data. The complexity measure may comprise the entropy of the EEG signal data. The EEG signal data complexity measure is used as the feedback signal in a control loop for an anesthetic delivery unit to control hypnotic drug administration to the patient in a manner that provides the desired hypnotic level in the patient. An EEG signal complexity measure obtained from the cerebral activity of the patient can be advantageously used in conjunction with a measure of patient electromyographic (EMG) activity to improve the response time of hypnotic level determination and of the feedback control of drug administration. A pharmacological transfer function may be used, along with pharmacokinetic and pharmacodynamic models.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: April 27, 2010
    Assignee: GE Healthcare Finland Oy
    Inventors: Hanna E. Viertio-Oja, Emmanuel-S Cohen-Laroque